In: Strategic Direction 18 (2002) 5, pp. 25-27
Recent years have seen the market opportunity for innovative bioscience products grow rapidly. For instance, the human clinical diagnostics field is now a $17 billion world‐wide market, and in specific sectors, such as point of care (POC) and over the counter (OTC), there is an increasing...